Abstract:Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying therapies. Peptide-based biotherapeutics have become an attractive area of research due to their favorable properties such as high selectivity and affinity, chemical modifiability, good tissue permeability, and easy metabolism and excretion. Phage display, a powerful technique for identifying peptides with high affinity and specificity for their target molecules, has emerged as a key tool in the discovery of peptide-based drugs. Phage display technology involves the use of bacteriophages to express peptide libraries, which are then screened against a target of interest to identify peptides with desired properties. This approach has shown great promise in cancer diagnosis and treatment, with potential applications in targeting cancer cells and developing new therapies. In this comprehensive review, we provide an overview of the basic biology of phage vectors, the principles of phage library construction, and various methods for binding affinity assessment. We then describe the applications of phage display in pancreatic cancer therapy, targeted drug delivery, and early detection. Despite its promising potential, there are still challenges to be addressed, such as optimizing the selection process and improving the pharmacokinetic properties of phage-based drugs. Nevertheless, phage display represents a promising approach for the development of novel targeted therapies in pancreatic cancer and other tumors. Graphical abstract

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma

[Bio-Panning of Antagonistic Peptides Against HAb18G/CD147 and Their Function of Anti-Hepatoma Invasion].

THE FURTHER CHARACTERIZATION OF THE SPECIFICALLY BINDING PEPTIDE TO HEPATOCELLULAR CARCINOMA

Detection of Hepatocellular Carcinoma in an Orthotopic Patient-Derived Xenograft with an Epithelial Cell Adhesion Molecule-Specific Peptide

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Phage display screening of therapeutic peptide for cancer targeting and therapy

Screening Tumor-Targeting Bacteriophage Particles by Pre-Clearing Phage Display

Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting

Multi-modal Imaging for Uptake of Peptide Ligand Specific for CD44 by Hepatocellular Carcinoma

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

Identification of a peptide binding to cancer antigen Kita‐kyushu lung cancer antigen 1 from a phage‐display library

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells

Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.

Targeting of Hepatoma Cell and Suppression of Tumor Growth by A Novel 12mer Peptide Fused to Superantigen Tsst-1

Screening and Optimization of Phage Display Cyclic Peptides Against the WDR5 WBM Site

Screening for serum binding proteins in subjects with primary hepatocellular carcinoma using a phage display system

Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library

Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.